Noninvasive Prenatal Screening: Battleground In Diagnostics Innovation

Four companies have brought noninvasive prenatal testing to the market within the past two years. Its dramatic, rapid uptake has triggered a backlash among many geneticists, who fear the consequences of a poorly understood – and overhyped – technology.

More from Innovation

More from In Vivo